Professional background

Neelam Kumar qualified in Medicine from Oxford and Cambridge Universities subsequently training in respiratory medicine in the North West Thames deanery.

She was awarded a presitigious Wellcome-UCL Clinical PhD fellowship in 2014 to study novel personalised therapies in mesothelioma.

She was subsequently awarded a NIHR academic clinical lectureship to develop a novel anti-cancer drug based on findings from her PhD.

Her clinical and research interests include thoracic malignancies, pleural disease and drug discovery/development.

Research interests

Lung cancer, mesothelioma, pleural disease, drug discovery/development


Busacca S, O’ Regan L, Singh S, Sharkey AJ, Dawson AG, Dzialo J, Parsons A, *Kumar N Fennell DA. BRCA1/MAD2L1 deficiency disrupts the spindle assembly checkpoint to confer vinorelbine resistance in mesothelioma. Molecular Cancer Therapeutics 2020

*Kumar N, Alrifai D, Psallidas I. Palliative care in mesothelioma: are current services RESPECT-able enough? Thorax 2019, Apr;74(4):326-327.

*Kumar N, Alrifai D, Kolluri KK, Sage EK, Ishii Y, Borg E, Falzon M, Nicholson A, Janes SM. Analysis of BAP1 expression to predict the clinical activity of systemic cytotoxic chemotherapy in mesothelioma. Lung Cancer 2019 Jan;127:164-166.

Kolluri KK, *Alifrangis C,  *Kumar N, McDermott U, Janes SM. Loss of functional BAP1 augments sensitivity to TRAIL in cancer cells.  eLife 2018 Jan 18;7. pii: e30224. doi: 10.7554/eLife.30224

 *Kumar N, Price L, Dimopoulos K, Wells AJ, Wort SJ. Pulmonary tumour thrombotic microangiopathy: unclassifiable pulmonary hypertension?  European Respiratory Journal 2015 Oct;46(4):1214-7.

Gatheral T,  Kumar N, Sansom B, Lai D, Nair A, Vlahos I, Baker EH. COPD related bronchiectasis; independent impact on disease course and outcomes.  Journal of Chronic Obstructive Pulmonary Disease 2014: 11(6):605-14.

 *Kumar N, Lewis DJ. Fever and rash in a returning traveller.  British Medical Journal 2012: 344:e2400.

 *Kumar N, Bazari F, Rhodes A, Chua F, Tinwell B. Chronic Pneumocystis jiroveci presenting as asymptomatic granulomatous pulmonary nodules in lymphoma.  Journal of Infection 2011: 62(6):484-6.

 *Kumar N. Lectin mediated defences are important in limiting disease in influenza . Thorax 2011. DOI: 10.1136/thoraxjnl-2011-200358